Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model

European Journal of Neuroscience

Volumn 26, Issue 2, 2007, Pages 413-416

  Butovsky, Oleg ^a,b   Kunis, Gilad ^a   Koronyo Hamaoui, Maya ^a   Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CD11c; Chimeric mice; Diphtheria toxin receptor; Glatiramer acetate; Inflammation; Neurodegeneration

Indexed keywords

AMYLOID; DIPHTHERIA TOXIN; GLATIRAMER;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; DENDRITIC CELL; GENE EXPRESSION; IMMUNIZATION; INJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TRANSGENE;

ALZHEIMER DISEASE; ANIMALS; ANTIGENS, CD11C; BONE MARROW TRANSPLANTATION; CELL COUNT; CHIMERA; DENDRITIC CELLS; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MICROGLIA; PEPTIDES; SENILE PLAQUES;

EID: 34447644067     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05652.x     Document Type: Article

References (26)

1. Aharoni, R., Teitelbaum, D., Leitner, O., Meshorer, A., Sela, M. Arnon, R. (2000) Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. Proc. Natl Acad. Sci. USA, 97, 11472 11477.
2. Angelov, D.N., Waibel, S., Guntinas-Lichius, O., Lenzen, M., Neiss, W.F., Tomov, T.L., Yoles, E., Kipnis, J., Schori, H., Reuter, A., Ludolph, A. Schwartz, M. (2003) Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA, 100, 4790 4795.
3. Bakalash, S., Shlomo, G.B., Aloni, E., Shaked, I., Wheeler, L., Ofri, R. Schwartz, M. (2005) T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure. J. Mol. Med., 83, 904 916.
4. Bechmann, I., Goldmann, J., Kovac, A.D., Kwidzinski, E., Simburger, E., Naftolin, F., Dirnagl, U., Nitsch, R. Priller, J. (2005) Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia. Faseb J., 19, 647 649.
5. Beers, D.R., Henkel, J.S., Xiao, Q., Zhao, W., Wang, J., Yen, A.A., Siklos, L., McKercher, S.R. Appel, S.H. (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA, 103, 16021 16026.
6. Benner, E.J., Mosley, R.L., Destache, C.J., Lewis, T.B., Jackson-Lewis, V., Gorantla, S., Nemachek, C., Green, S.R., Przedborski, S. Gendelman, H.E. (2004) Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc. Natl Acad. Sci. USA, 101, 9435 9440.
7. Borchelt, D.R., Ratovitski, T., van Lare, J., Lee, M.K., Gonzales, V., Jenkins, N.A., Copeland, N.G., Price, D.L. Sisodia, S.S. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron, 19, 939 945.
8. Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H. Schwartz, M. (2006) Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl Acad. Sci. USA, 103, 11784 11789.
9. Corti, S., Locatelli, F., Donadoni, C., Guglieri, M., Papadimitriou, D., Strazzer, S., Del Bo, R. Comi, G.P. (2004) Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain, 127, 2518 2532.
10. Duda, P.W., Schmied, M.C., Cook, S.L., Krieger, J.I. Hafler, D.A. (2000) Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest., 105, 967 976.
11. Frenkel, D., Maron, R., Burt, D.S. Weiner, H.L. (2005) Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. J. Clin. Invest., 115, 2423 2433.
12. Hardy, J. Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353 356.
13. Hess, D.C., Abe, T., Hill, W.D., Studdard, A.M., Carothers, J., Masuya, M., Fleming, P.A., Drake, C.J. Ogawa, M. (2004) Hematopoietic origin of microglial and perivascular cells in brain. Exp. Neurol., 186, 134 144.
14. Hickey, W.F. Kimura, H. (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science, 239, 290 292.
15. Jankowsky, J.L., Fadale, D.J., Anderson, J., Xu, G.M., Gonzales, V., Jenkins, N.A., Copeland, N.G., Lee, M.K., Younkin, L.H., Wagner, S.L., Younkin, S.G. Borchelt, D.R. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet., 13, 159 170.
16. Jung, S., Unutmaz, D., Wong, P., Sano, G., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., Pamer, E.G., Littman, D.R. Lang, R.A. (2002) In vivo depletion of CD11c (+) dendritic cells abrogates priming of CD8 (+) T cells by exogenous cell-associated antigens. Immunity, 17, 211 220.
17. Kipnis, J., Mizrahi, T., Hauben, E., Shaked, I., Shevach, E. Schwartz, M. (2002) Neuroprotective autoimmunity: naturally occurring CD4 + CD25 + regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc. Natl Acad. Sci. USA, 99, 15620 15625.
18. Kipnis, J., Yoles, E., Porat, Z., Cohen, A., Mor, F., Sela, M., Cohen, I.R. Schwartz, M. (2000) T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc. Natl Acad. Sci. USA, 97, 7446 7451.
19. Malm, T.M., Koistinaho, M., Parepalo, M., Vatanen, T., Ooka, A., Karlsson, S. Koistinaho, J. (2005) Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol. Dis., 18, 134 142.
20. Miller, A., Shapiro, S., Gershtein, R., Kinarty, A., Rawashdeh, H., Honigman, S. Lahat, N. (1998) Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation. J. Neuroimmunol., 92, 113 121.
21. Schori, H., Kipnis, J., Yoles, E., WoldeMussie, E., Ruiz, G., Wheeler, L.A. Schwartz, M. (2001) Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc. Natl Acad. Sci. USA, 98, 3398 3403.
22. Selkoe, D.J. (1991) The molecular pathology of Alzheimer's disease. Neuron, 6, 487 498.
23. Simard, A.R. Rivest, S. (2004) Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. Faseb J., 18, 998 1000.
24. Simard, A.R., Soulet, D., Gowing, G., Julien, J.P. Rivest, S. (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron, 49, 489 502.
25. Streit, W.J. (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia, 40, 133 139.
26. Streit, W.J. (2006) Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci., 29, 506 510.